Metazym
From Self-sufficiency
Revision as of 23:03, 7 July 2010 by Cydebot (Talk) (Robot - Moving category Future products to Upcoming products per CFD at Wikipedia:Categories for discussion/Log/2010 June 14.)
Metazym is being trialed in Patients with late infantile Metachromatic Leukodystrophy[1]. The drug produced by Shire costs in the vicinity of US$90,000 per month [2]. A company spokesman notes that the drug will not be on the market until at least 2012
